SWOG S2611 (ARCIS) A Randomized Comparison of Intravesical Therapies: A phase III study of cretostimogene grenadenorepvec/gemcitabine (CRETO-GEM) versus gemcitabine/docetaxel (GEM-DOCE) for the treatment of BCG-unresponsive and BCG-exposed NMIBC

SWOG S2611 (ARCIS) A Randomized Comparison of Intravesical Therapies: A phase III study of cretostimogene grenadenorepvec/gemcitabine (CRETO-GEM) versus gemcitabine/docetaxel (GEM-DOCE) for the treatment of BCG-unresponsive and BCG-exposed NMIBC

Sunday, May 17, 2026 9:08 AM to 9:16 AM · 8 min. (America/New_York)
Hall B, The Square, Learning Lab
Detail
Oncology: Bladder

Registered attendees

Seth Lerner
Seth Lerner
Vice Chair for Faculty AffairsBaylor College of Medicine Scott Department of Urology

Log in

See all the content and easy-to-use features by logging in or registering!